Raphael Pharmaceutical names Uri Tadelis CFO after Guy Ofir resignation - RAPH News | RalliesRaphael Pharmaceutical names Uri Tadelis CFO after Guy Ofir resignation
R
RAPH• CFO and board changes
- Raphael Pharmaceutical named Uri Tadelis chief financial officer, effective July 16, 2026.
- Guy Ofir resigned as CFO, general counsel, and director, effective July 16, 2026; no dispute was cited.
- Ajay Kumar Dhadha resigned as board chairman and director, effective June 30, 2026; no dispute was cited.
